Sanofi Aktie

102,72EUR
-1,02EUR
-0,98%
19:28:40
103,72EUR
-0,08EUR
-0,08%
17:50:05

WKN: 920657 / ISIN: FR0000120578

  Kaufen  
Verkaufen
oder
Werbung

Sanofi Aktien News

26.04.22
Press Release: Sanofi teams up with McLaren Racing to accelerate industrial excellence (EN, Sanofi-Aventis)
26.04.22Press Release: Sanofi teams up with McLaren Racing to accelerate industrial excellence (GlobeNewswire)
26.04.22
Sanofi - Aventis Groupe : Press Release: Sanofi teams up with McLaren Racing to accelerate industrial excellence (Investegate)
27.04.22
Should You Buy Sanofi (SNY) Ahead of Earnings? (Zacks)
28.04.22
Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1 (EN, Sanofi-Aventis)
28.04.22
Sanofi - Aventis Groupe : Press Release: Sanofi continues to deliver strong business EPS growth driven by higher sales and improved margins in Q1 (Investegate)
28.04.22
Sanofi (SNY) Q1 Earnings Top, Vaccines Recover, CHC Sales Rise (Zacks)
29.04.22
Sanofi (SNY) Q1 2022 Earnings Call Transcript (MotleyFool)
03.05.22Press Release: Annual General Meeting of May 3, 2022 (GlobeNewswire)
03.05.22
Press Release: Annual General Meeting of May 3, 2022 (EN, Sanofi-Aventis)
04.05.22Press Release: Foundation S: Sanofi’s new philanthropic spearhead (GlobeNewswire)
04.05.22
Press Release: Foundation S: Sanofi’s new philanthropic spearhead (EN, Sanofi-Aventis)
11.05.22Press Release: New nirsevimab data analyses reinforce efficacy against RSV (GlobeNewswire)
11.05.22
Press Release: New nirsevimab data analyses reinforce efficacy against RSV (EN, Sanofi-Aventis)
11.05.22
Sanofi - Aventis Groupe : Press Release: New nirsevimab data analyses reinforce efficacy against RSV (Investegate)
15.05.22Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy (GlobeNewswire)
15.05.22
Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy (EN, Sanofi-Aventis)
17.05.22
Unilever and Sanofi pile on pressure over 2035 EU petrol ban (Financial Times)
17.05.22
Media Update: New data from fast-growing innovative Oncology pipeline and portfolio to be presented at 2022 ASCO Annual Meeting (EN, Sanofi-Aventis)
20.05.22
Media Update: CHMP recommends approval of Xenpozyme® (olipudase alfa), the first and only treatment for ASMD (EN, Sanofi-Aventis)
20.05.22FDA Approves Dupixent® (dupilumab) as First Treatment for Adults and Children Aged 12 and Older with Eosinophilic Esophagitis (PR Newswire)
20.05.22Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis (GlobeNewswire)
20.05.22
Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis (EN, Sanofi-Aventis)
23.05.22
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Zacks)
24.05.22
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth Group, Costco Wholesale, Cisco Systems and Sanofi (Zacks)
25.05.22
Sanofi, Regeneron's Dupixent Gets FDA Nod for 4th Indication (Revised) (Zacks)

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln